MedPath

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%

Approved
Approval ID

897e88a9-c010-22f1-e053-2a95a90afdb2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 22, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-1022
Product Classification
G
Generic Name
BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 22, 2019
FDA Product Classification

INGREDIENTS (4)

TRETINOINActive
Quantity: 0.025 g in 100 g
Code: 5688UTC01R
Classification: ACTIB
BENZOYL PEROXIDEActive
Quantity: 2.5 g in 100 g
Code: W9WZN9A0GM
Classification: ACTIB
CLINDAMYCIN PHOSPHATEActive
Quantity: 1 g in 100 g
Code: EH6D7113I8
Classification: ACTIB
NIACINAMIDEActive
Quantity: 2 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025% - FDA Drug Approval Details